Showing 1,201 - 1,220 results of 102,708 for search '(( 5 c decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.71s Refine Results
  1. 1201
  2. 1202

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  3. 1203
  4. 1204
  5. 1205
  6. 1206
  7. 1207

    The wound healing microenvironment restored GJIC but did not directly decrease tumor cells. by Linxin Liu (829738)

    Published 2015
    “…Images were taken at ×10 magnification. (B and C) The combination of three compounds led to angiogenesis and optimal fibroblast proliferation but did not directly decrease A549 cancer cells. …”
  8. 1208
  9. 1209
  10. 1210

    Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

    Published 2009
    “…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
  11. 1211

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”
  12. 1212
  13. 1213
  14. 1214
  15. 1215

    PLD inhibitors decrease PLD2 expression in foci of lungs following xenotransplantation. by Karen M. Henkels (3350273)

    Published 2016
    “…<p>(<b>A</b>) Primary tumor volume from xenotransplanted mice in the presence or absence (“control” = vehicle only) of PLD inhibitors delivered by Alzet pumps, as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0166553#pone.0166553.g001" target="_blank">Fig 1</a> legend. …”
  16. 1216

    Decreased 11ß-HSD1 protein level by IGF-I overexpression <i>in vivo</i> and a direct treatment with IGF-I. by Subrata Chowdhury (787208)

    Published 2015
    “…<p><b>A</b>. IGF-I overexpression decreased the levels of 11ß-HSD1 in pancreatic islets, liver and visceral fat, shown in Western blots. …”
  17. 1217
  18. 1218
  19. 1219
  20. 1220